BrachyDOSE‘s success in Jumpstarter Next program

Brachydose has successfully completed the EIT Jumpstarter Next program winning the 1st place at the grand finale in Budapest, Hungary. Only 3 startups, who entered the program, made it to the grand finale. We were competing together with Cropler and Biopols.

For Brachydose, participation in Jumpstarter Next was a great opportunity to strengthen our go-to-market strategy, prepare for the regulatory and clinical expansion, as well as connect with investors and industry partners.

We want to say THANK YOU to EIT Jumpstarter for accepting us to the programme, to EIT Health InnoStars and EIT Community Hub Lithuania for constant support, EIT - European Institute of Innovation and Technology for great organization of Grand Finale event in Budapest.

About the Jumpstarter Next program

Designed and supported by the European Institute of Innovation & Technology (EIT), Jumpstarter Next focuses on founders from the EIT Regional Innovation Scheme (RIS)—regions that show high innovation potential but historically lower access to funding, networks, and commercialization support. The program bridges this gap by connecting emerging ventures with top-tier mentors, corporate partners, and investors across Europe.

Unlike the original EIT Jumpstarter, which helps innovators shape early concepts, Jumpstarter Next is aimed at startups that have already completed initial validation, prototypes, or proof-of-concept work.

Jumpstarter Next offers a structured, multi-month program with training sessions, business development workshops, investor pitching, and one-on-one mentorship. Teams work closely with EIT experts from multiple Knowledge and Innovation Communities (KICs), drawing on Europe’s deep resources in health, manufacturing, energy, climate, urban mobility, raw materials, and food innovation.